Subgroup-specific target of nt-probnp level in heart failure with preserved ejection fraction

被引:0
|
作者
Sakamoto, Daisuke [1 ]
Sotomi, Y. [1 ]
Nakatani, D. [1 ]
Okada, K. [1 ]
Seo, M. [2 ]
Yano, M. [3 ]
Hyashi, T. [4 ]
Nakagawa, A. [5 ]
Nakagawa, Y. [6 ]
Tamaki, S. [7 ]
Yasumura, Y. [5 ]
Yamada, T. [2 ]
Hikoso, S. [8 ]
Sakata, Y. [1 ]
机构
[1] Osaka Univ, Grad Sch Med, Osaka, Japan
[2] Osaka Gen Med Ctr, Osaka, Japan
[3] Osaka Rosai Hosp, Cardiol, Osaka, Japan
[4] Osaka Police Hosp, Cardiol, Osaka, Japan
[5] Amagasaki Chuo Hosp, Amagasaki, Hyogo, Japan
[6] Kawanishi City Hosp, Kawanishi, Japan
[7] Rinku Gen Med Ctr, Osaka, Japan
[8] Nara Med Univ, Nara, Japan
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:53 / 54
页数:2
相关论文
共 50 条
  • [41] NT-proBNP, galectin-3 and proANT levels in non-acute senile patients with heart failure with preserved ejection fraction
    Malinova, L.
    Podbolotov, R.
    Povarova, T.
    Matveev, I.
    Denisova, T.
    EUROPEAN JOURNAL OF HEART FAILURE, 2014, 16 : 76 - 76
  • [42] CA125 outperforms NT-proBNP in the prediction of maximum aerobic capacity in heart failure with preserved ejection fraction and kidney dysfunction
    Nunez-Marin, Gonzalo
    Palau, Patricia
    Dominguez, Eloy
    de la Espriella, Rafael
    Lopez, Laura
    Flor, Cristina
    Marin, Paloma
    Lorenzo, Miguel
    Minana, Gema
    Bodi, Vicent
    Sanchis, Juan
    Nunez, Julio
    CLINICAL KIDNEY JOURNAL, 2024, 17 (08)
  • [43] The Role of NT-proBNP Levels in the Diagnosis and Treatment of Heart Failure with Preserved Ejection Fraction-It Is Not Always a Hide-and-Seek Game
    Chrysohoou, Christina
    Konstantinou, Konstantinos
    Tsioufis, Kostas
    JOURNAL OF CARDIOVASCULAR DEVELOPMENT AND DISEASE, 2024, 11 (07)
  • [44] CA125 outperforms NT-proBNP in the prediction of maximum aerobic capacity in heart failure with preserved ejection fraction and cardiorenal syndrome
    Nunez Marin, G. Gonzalo
    Palau, P.
    De La Espriella, R.
    Lorenzo Hernandez, M.
    Gasull, A.
    Montiel, J.
    Nunez, J.
    EUROPEAN JOURNAL OF HEART FAILURE, 2024, 26 : 260 - 260
  • [45] Impact of renal denervation treatment on NT-proBNP level and Six-Minute Walk Test in patients with resistant hypertension and heart failure with preserved ejection fraction
    Moiseeva, Anna
    Caraus, A.
    Moscalu, V.
    Ciobanu, N.
    Abras, M.
    Cociu, M.
    EUROPEAN JOURNAL OF HEART FAILURE, 2023, 25 : 227 - 227
  • [46] Baseline NT-proBNP and responsiveness to autonomic regulation therapy in patients with heart failure and reduced ejection fraction
    Anand, Inder
    Ardell, Jeffrey L.
    Gregory, Doug
    Libbus, Imad
    DiCarlo, Lorenzo
    Premchand, Rajendra K.
    Sharma, Kamal
    Mittal, Sanjay
    Monteiro, Rufino
    IJC HEART & VASCULATURE, 2020, 29
  • [47] Vericiguat and NT-proBNP in patients with heart failure with reduced ejection fraction: analyses from the VICTORIA trial
    Senni, Michele
    Lopez-Sendon, Jose
    Cohen-Solal, Alain
    Ponikowski, Piotr
    Nkulikiyinka, Richard
    Freitas, Cecilia
    Vlajnic, Vanja Miodrag
    Roessig, Lothar
    Pieske, Burkert
    ESC HEART FAILURE, 2022, 9 (06): : 3791 - 3803
  • [48] SACUBITRIL / VALSARTAN IN PATIENTS WITH HEART FAILURE AND REDUCED EJECTION FRACTION: COMPARATIVE PROFILE OF NT-PROBNP AND BNP
    Ajello, L.
    Romano, G.
    Agnese, V.
    Bellavia, D.
    Di Gesaro, G.
    Falletta, C.
    La Franca, E.
    Mina, C.
    Storniolo, S.
    Clemenza, F.
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2019, 21 (0E) : E223 - E224
  • [49] "Worsening Heart Failure" in Chronic Heart Failure With Reduced Ejection Fraction: Definition, Characteristics, and Effects of NT-proBNP Guided Therapy
    Mallick, Aditi
    Gandhi, Parul U.
    Gaggin, Hanna K.
    Januzzi, James L.
    CIRCULATION, 2015, 132
  • [50] Heart failure with preserved ejection fraction: A moving target
    Moura, Brenda
    REVISTA PORTUGUESA DE CARDIOLOGIA, 2013, 32 (09) : 653 - 655